Why is Parmax Pharma falling/rising?

As of 06-Aug, Parmax Pharma Ltd's stock price is currently at 37.99, reflecting an increase of 0.51, or 1.36%. Today's performance indicates that the stock has outperformed its sector by 3.42%. However, it is important to note that while the stock is higher than its 5-day moving averages, it remains below the 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has shown a slight gain of 0.16%, but it has declined by 1.96% over the past month and is down 14.15% year-to-date. The delivery volume has significantly decreased, falling by 95.07% against the 5-day average, indicating a drop in investor participation, which could negatively impact future price movements.
In the broader market context, the Sensex has experienced a decline of 1.15% over the past week and 3.46% over the past month, while Parmax Pharma's recent performance has been relatively better in the short term. Despite the stock's recent uptick, its year-to-date performance is notably poor compared to the benchmark, which has gained 3.08% this year. Additionally, the Pharmaceuticals & Drugs sector has seen a decline of 2.17%, suggesting that the overall market sentiment in this sector is negative, which could be influencing investor behavior and contributing to the stock's volatility.